21 CFR 369.10
§ 369.10 Conspicuousness of warning statements.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 369.10, § 369.10 Conspicuousness of warning statements, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/86775
- Permanent ID
ys:prov:86775@1- SHA-256
72f4f42df5e5b178a3d24ad8172096dd94c4633ed141e931d25ac1c1a5bf597b
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
Necessary warning statements should appear in the labeling prominently and conspicuously as compared to other words, statements, designs, and devices, and in bold type on clearly contrasting background, in order to comply with the provisions of section 502(c) and (f)(2) of the act. The warning statements should be placed in the labeling in juxtaposition with the directions for use and, in any case, should appear on the label when there is sufficient label space in addition to mandatory label information.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.